• Breathing Easier: How Aficamten is Giving New Hope to HCM Patients

  • Feb 9 2025
  • Length: 16 mins
  • Podcast

Breathing Easier: How Aficamten is Giving New Hope to HCM Patients

Listen for free

View show details

  • Summary

  • In this episode, we dive into the lives of patients with hypertrophic cardiomyopathy (HCM) and how Aficamten is offering them hope for a better future. From breathing easier to avoiding surgery, we’ll uncover the real impact of this new treatment backed by the SEQUOIA-HCM trial. If you care about heart health or know someone living with HCM, this one’s for you.


    Links to the Podcast

    • Apple Podcast:⁠⁠Listen on Apple Podcast⁠⁠
    • Spotify:⁠⁠Listen on Spotify⁠⁠
    • Amazon Music:⁠⁠Listen on Amazon Music⁠⁠
    • YouTube:⁠⁠Watch on YouTube⁠⁠


    📝Source:

    Study Title: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM Trial)

    Publication Date: May 13, 2024

    NEJM.org - SEQUOIA-HCM Trial

    🔗Full Study Details:NEJM - SEQUOIA-HCM Study
    🔗ClinicalTrials.gov:SEQUOIA-HCM NCT05186818


    #BreathingEasier #HeartHealth #Aficamten #NewHope #SEQUOIAHCM #CardiologyTalk #Podcast #RealImpact #MedicalBreakthroughs #BetterLiving
    Show More Show Less
Show More Show Less

What listeners say about Breathing Easier: How Aficamten is Giving New Hope to HCM Patients

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.